Recurrent Acute Myeloid Leukemia

specific

The reemergence of acute myeloid leukemia after a period of remission.

34

Centers

71

Active Trials

Cancer Funding

Top Centers for Recurrent Acute Myeloid Leukemia(34)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
73.3
2
NCI Comprehensive
High-Volume Research Center
70.0
370.0
4
High-Volume Research Center
70.0
5
High-Volume Research Center
70.0
6
NCI Comprehensive
Active Research Program
64.0
7
NCI Comprehensive
Active Research Program
64.0
8
NCI Comprehensive
Active Research Program
64.0
9
NCI Comprehensive
Active Research Program
64.0
10
NCI Clinical
Active Research Program
64.0
11
NCI Comprehensive
Active Research Program
53.5
12
NCI Comprehensive
Active Research Program
53.5
13
NCI Comprehensive
Active Research Program
53.5
14
NCI Comprehensive
Active Research Program
53.5
15
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
53.5
16
NCI Comprehensive
Active Research Program
53.5
17
NCI Comprehensive
Active Research Program
53.5
18
NCI Comprehensive
Active Research Program
53.5
19
NCI Comprehensive
Active Research Program
53.5
20
NCI Comprehensive
Active Research Program
53.5
21
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
53.5
22
NCI Comprehensive
Active Research Program
37.6
23
NCI Comprehensive
Active Research Program
37.6
24
NCI Comprehensive
Active Research Program
37.6
25
NCI Comprehensive
Active Research Program
37.6
26
NCI Comprehensive
Active Research Program
37.6
27
NCI Clinical
Active Research Program
37.6
28
Active Research Program
37.6
29
NCI Comprehensive
Active Research Program
37.6
30
Active Research Program
37.6
31
Active Research Program
37.6
32
Active Research Program
37.6
33
Active Research Program
37.6
34
Active Research Program
37.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →